ISCHEMIA-EXTEND (Extended Follow-up)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT04894877

Recruitment Status : Active, not recruiting

First Posted : May 20, 2021

Last Update Posted : September 21, 2022

View this study on Beta.ClinicalTrials.gov

Sponsor:

Collaborators:

New York University

Stanford University

National Heart, Lung, and Blood Institute (NHLBI)

Duke University

Information provided by (Responsible Party):

NYU Langone Health

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Active, not recruiting
Estimated Primary Completion Date :	March 31, 2026
Estimated Study Completion Date :	March 31, 2026

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Hochman JS, Anthopolos R, Reynolds HR, Bangalore S, Xu Y, O'Brien SM, Mavromichalis S, Chang M, Contreras A, Rosenberg Y, Kirby R, Bhargava B, Senior R, Banfield A, Goodman SG, Lopes RD, Pracon R, Lopez-Sendon J, Maggioni AP, Newman JD, Berger JS, Sidhu MS, White HD, Troxel AB, Harrington RA, Boden WE, Stone GW, Mark DB, Spertus JA, Maron DJ; ISCHEMIA-EXTEND Research Group. Survival After Invasive or Conservative Management of Stable Coronary Disease. Circulation. 2023 Jan 3;147(1):8-19. doi: 10.1161/CIRCULATIONAHA.122.062714. Epub 2022 Nov 6.

To Top